Faysal Dane

2.2k total citations
131 papers, 1.3k citations indexed

About

Faysal Dane is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Faysal Dane has authored 131 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Oncology, 64 papers in Pulmonary and Respiratory Medicine and 30 papers in Surgery. Recurrent topics in Faysal Dane's work include Colorectal Cancer Treatments and Studies (27 papers), Gastric Cancer Management and Outcomes (21 papers) and Cancer Treatment and Pharmacology (17 papers). Faysal Dane is often cited by papers focused on Colorectal Cancer Treatments and Studies (27 papers), Gastric Cancer Management and Outcomes (21 papers) and Cancer Treatment and Pharmacology (17 papers). Faysal Dane collaborates with scholars based in Türkiye, United States and United Kingdom. Faysal Dane's co-authors include Perran Fulden Yumuk, Gül Başaran, Mahmut Gümüş, Nazım Serdar Turhal, Mehmet Aliustaoğlu, Mesut Şeker, Süleyman Buyukberber, Taflan Salepçi, Ahmet Bılıcı and Beste M. Atasoy and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Faysal Dane

126 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Faysal Dane Türkiye 19 757 484 303 237 184 131 1.3k
Abdurrahman Işıkdoğan Türkiye 19 537 0.7× 424 0.9× 204 0.7× 102 0.4× 204 1.1× 146 1.2k
Beodeul Kang South Korea 21 756 1.0× 373 0.8× 322 1.1× 198 0.8× 147 0.8× 99 1.4k
Keiichiro Ishibashi Japan 19 809 1.1× 522 1.1× 588 1.9× 87 0.4× 164 0.9× 194 1.5k
P. Kienle Germany 21 1.0k 1.4× 359 0.7× 845 2.8× 148 0.6× 116 0.6× 73 1.7k
Deniz Tural Türkiye 17 478 0.6× 377 0.8× 217 0.7× 89 0.4× 116 0.6× 121 938
Masato Ozaka Japan 21 1.2k 1.6× 581 1.2× 525 1.7× 268 1.1× 188 1.0× 186 1.5k
İrfan Çiçin Türkiye 21 1.2k 1.6× 901 1.9× 338 1.1× 188 0.8× 259 1.4× 141 1.9k
Felice N. van Erning Netherlands 23 997 1.3× 416 0.9× 597 2.0× 109 0.5× 76 0.4× 90 1.5k
Winnie Ricker United States 13 282 0.4× 602 1.2× 357 1.2× 289 1.2× 100 0.5× 21 1.3k
Seong Yoon Yi South Korea 22 487 0.6× 466 1.0× 301 1.0× 88 0.4× 251 1.4× 70 1.2k

Countries citing papers authored by Faysal Dane

Since Specialization
Citations

This map shows the geographic impact of Faysal Dane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faysal Dane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faysal Dane more than expected).

Fields of papers citing papers by Faysal Dane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faysal Dane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faysal Dane. The network helps show where Faysal Dane may publish in the future.

Co-authorship network of co-authors of Faysal Dane

This figure shows the co-authorship network connecting the top 25 collaborators of Faysal Dane. A scholar is included among the top collaborators of Faysal Dane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faysal Dane. Faysal Dane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dane, Faysal, Erdem Göker, Kazım Uygun, et al.. (2025). Regional and Gender-Based Distribution of KRAS Mutations in Metastatic Colorectal Cancer Patients in Turkey: An Observational Study. Medicina. 61(4). 694–694.
2.
Telli, Tuğba Akın, Çiğdem Çelikel, İbrahim Vedat Bayoğlu, et al.. (2023). Prognostic significance of mucinous histology in left‑sided metastatic colorectal cancers with wild‑type RAS and evaluation of backbone chemotherapy regimens. Oncology Letters. 25(5). 208–208. 2 indexed citations
3.
Özet, Ahmet, Faysal Dane, Nuri Faruk Aykan, et al.. (2022). Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey. Future Oncology. 18(29). 3267–3276. 2 indexed citations
4.
Telli, Tuğba Akın, Mehmet Akif Öztürk, Özkan Alan, et al.. (2022). Real-world assessment of quality-of-life in patients with breast cancer treated with adjuvant endocrine therapy. Future Oncology. 18(22). 2425–2439.
5.
Telli, Tuğba Akın, İlker Tınay, Trevor Jones, et al.. (2022). Prognostic significance of 18F-FDG PET/CT indices in metastatic renal cell cancer and evaluation of revised IMDC risk model by including 18F-FDG PET-CT parameters. Acta Radiologica. 64(5). 2040–2049. 2 indexed citations
6.
Ma, Kaplan, Zeynep Oruç, Mahmut Gümüş, et al.. (2020). The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study.. PubMed. 24(3). 1081–1086. 1 indexed citations
7.
Telli, Tuğba Akın, et al.. (2020). QT interval prolongation related to afatinib treatment in a patient with metastatic non–small-cell lung cancer. Current Problems in Cancer. 44(6). 100594–100594. 4 indexed citations
8.
Dane, Faysal, Şuayib Yalçın, Mustafa Beneklı, et al.. (2020). Safety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study. BMJ Open. 10(3). e027665–e027665. 9 indexed citations
9.
Telli, Tuğba Akın, et al.. (2020). A rare case of gastric cancer with bilateral breast metastasis during pregnancy. Journal of Oncology Pharmacy Practice. 27(1). 220–226. 5 indexed citations
10.
Telli, Tuğba Akın, İlker Ökten, Özkan Alan, et al.. (2020). VEGF-VEGFR pathway seems to be the best target in hepatic epithelioid hemangioendothelioma: A case series with review of the literature. Current Problems in Cancer. 44(5). 100568–100568. 11 indexed citations
11.
Alan, Özkan, Tuğba Akın Telli, Özlem Erçelep, et al.. (2020). Prognostic value of modified Glasgow prognostic score in recurrent high-grade glial tumors treated with systemic treatment. Clinical Neurology and Neurosurgery. 196. 105976–105976. 4 indexed citations
12.
Erçelep, Özlem, Özkan Alan, Tuğba Akın Telli, et al.. (2020). Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma. Tumori Journal. 107(3). 231–237. 5 indexed citations
13.
Telli, Tuğba Akın, et al.. (2020). Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature. Current Problems in Cancer. 45(2). 100668–100668. 7 indexed citations
14.
Alan, Özkan, Tuğba Akın Telli, Özlem Erçelep, et al.. (2020). Prognostic factors in progressive high-grade glial tumors treated with systemic approach: A single center experience. Journal of Oncology Pharmacy Practice. 27(2). 329–339. 2 indexed citations
15.
Kefeli, Umut, Murat Akyol, Ramazan Yıldız, et al.. (2013). Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experience.. PubMed. 60(124). 647–52. 4 indexed citations
16.
Korkmaz, Taner, S. Seber, Gül Başaran, et al.. (2012). Serum thymidine kinase 1 levels correlates with FDG uptake and prognosis in patients with non small cell lung cancer. Biomarkers. 18(1). 88–94. 11 indexed citations
17.
Atasoy, Beste M., et al.. (2012). Kanser Hastalarında Kemoradyoterapi Sırasında Beslenme Yönetiminde Disiplinler Arası İşbirliğinin Yeri: Bir Pilot Çalışma. Marmara medical journal. 25(1). 32–36. 1 indexed citations
18.
19.
Küçüköner, Mehmet, Abdurrahman Işıkdoğan, Mehmet Bilici, et al.. (2012). Adjuvant Chemoradiation for Gastric Cancer: Multicentric Study of the Anatolian Society of Medical Oncology. Hepatogastroenterology. 59(119). 2343–7. 3 indexed citations
20.
Kaya, Ali, Süleyman Buyukberber, Faysal Dane, et al.. (2010). Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancer.. PubMed. 96(3). 400–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdurrahman Işıkdoğan Breakdown of academic impact, for papers by Beodeul Kang Breakdown of academic impact, for papers by Keiichiro Ishibashi Breakdown of academic impact, for papers by P. Kienle Breakdown of academic impact, for papers by Deniz Tural Breakdown of academic impact, for papers by Masato Ozaka Breakdown of academic impact, for papers by İrfan Çiçin Breakdown of academic impact, for papers by Felice N. van Erning Breakdown of academic impact, for papers by Winnie Ricker Breakdown of academic impact, for papers by Seong Yoon Yi
Rankless by CCL
2026